Dr. Tilo Kunath’s research group focuses on mechanisms of neurodegeneration with two main areas; to understand how the protein, α-synuclein, causes degeneration of neurons in Parkinson’s, and to produce a cell-based therapy for Parkinson’s from human pluripotent stem cells. The group also uses patient-derived material to generate induced pluripotent stem cells (iPSCs) with genetic mutations known to cause Parkinson’s.